Personal page of Estefania Segalés
93 556 5903
Estefania Segalés is a researcher of the Catalan Institute of Cardiovascular Sciences (ICCC) from February, 2006. She participates of the investigation line "Molecular pathology of atherosclerosis illness" studying the signal transduction in platelet activation. She is responsible of the Cellular Culture Unit (2006), where is remarkable her supervision of the installation and technicians, the cryoconservation of samples and the application of in force regulations and GLP to the installation.
Graduated in biology for the Universitat de Girona (2000), he obtained the DEA. in biomedicine for the Universitat de Barcelona (UB) in 2003. She is waiting for presenting PhD. degree in biology for the same University. She has published 5 articles in scientific journals and some of her results have contributed to congress presentations.
- 2004
A novel anti-ischemic nitric oxide donor inhibits thrombosis without modifying haemodynamic parameters - 2004
Effects of a novel platelet NO-donor (LA816), aspirin, clopidogrel and combined therapy in inhibiting flow and lesion-dependent thrombosis in the porcine ex vivo model. - 2004
Inhibition of thrombosis by a novel platelet selective S-nitrosothiol compound without hemodynamic side effects - 2004
Moderate daily intake of red wine inhibits mural thrombosis and monocyte tissue factor expression in an experimental porcine model. - 2002
Pathogenesis of the acute coronary syndromes and therapeutic implications
-
Fisiopatología de la obesidad y nutrición
Molecular pathology of atherosclerosis illness -
Mecanismos celulares y moleculares en arteriosclerosis coronaria e isquemia miocárdica. Implicaciones Terapéuticas.
Molecular pathology of atherosclerosis illness
Catalan Institute of Cardiovascular Sciences
Hospital de la Santa Creu i Sant Pau, Pavelló del Convent
Sant Antoni Maria Claret, 167 08025 Barcelona
Spain
T: +34 - 93 556 5900 F: +34 - 93 556 5559